Preface |
|
vii | |
Acknowledgments |
|
ix | |
Contributor List |
|
xi | |
|
Section I Breast Cancer Overview |
|
|
1 | (112) |
|
1 Breast Cancer Epidemiology |
|
|
3 | (11) |
|
|
|
2 Breast Cancer Screening: Evidence and Recommendations |
|
|
14 | (4) |
|
|
|
3 Normal Breast Anatomy and Histology |
|
|
18 | (3) |
|
|
|
4 Proliferative Lesions and Breast Cancer Histopathology |
|
|
21 | (8) |
|
|
|
5 Breast Imaging Reporting and Data System (BI-RADS) |
|
|
29 | (19) |
|
|
6 An Overview of Digital Mammography Technology and MQSA Requirements |
|
|
48 | (15) |
|
|
|
7 Overview of Digital Breast Tomosynthesis |
|
|
63 | (9) |
|
|
8 Breast Ultrasound Overview |
|
|
72 | (9) |
|
|
|
9 Breast MRI Overview: Imaging Techniques and Equipment, Clinical Uses, Image Interpretation |
|
|
81 | (11) |
|
|
|
10 Breast Cancer Metastatic Imaging |
|
|
92 | (9) |
|
|
|
|
11 Emerging Breast Imaging Technologies |
|
|
101 | (5) |
|
|
12 Breast Cancer Staging and Treatment |
|
|
106 | (7) |
|
|
|
Section II Asymmetry, Mass, and Distortion |
|
|
113 | (182) |
|
|
115 | (15) |
|
|
|
|
130 | (14) |
|
|
|
15 Circumscribed Mass: Fibroadenoma |
|
|
144 | (6) |
|
|
16 Circumscribed Mass: Cysts, Complicated Cysts, Clustered Microcysts |
|
|
150 | (6) |
|
|
17 Circumscribed Mass: Intramammary Lymph Node |
|
|
156 | (3) |
|
|
18 Circumscribed Mass: Invasive Cancer |
|
|
159 | (8) |
|
|
19 Multiple Circumscribed Masses |
|
|
167 | (10) |
|
|
|
20 Fat-Containing, Circumscribed Mass(es) |
|
|
177 | (6) |
|
|
|
21 Large Circumscribed Mass in Young Female |
|
|
183 | (6) |
|
|
|
189 | (7) |
|
|
|
196 | (8) |
|
|
24 Mass with Indistinct Margins |
|
|
204 | (7) |
|
|
|
211 | (26) |
|
|
|
|
26 Multiple Irregular Masses |
|
|
237 | (7) |
|
|
|
27 Mass in Lactating Female |
|
|
244 | (7) |
|
|
|
28 Mass in Male (Gynecomastia, Cancer) |
|
|
251 | (9) |
|
|
|
29 Architectural Distortion (Cancer) |
|
|
260 | (9) |
|
|
30 Architectural Distortion (Radial Scar) |
|
|
269 | (9) |
|
|
31 Non-Mass Enhancement on MRI |
|
|
278 | (9) |
|
|
|
|
287 | (8) |
|
|
|
Section III Calcifications |
|
|
295 | (48) |
|
33 Dystrophic Calcifications |
|
|
297 | (4) |
|
|
34 Vascular Calcifications |
|
|
301 | (3) |
|
|
|
304 | (4) |
|
|
36 Secretory Calcifications |
|
|
308 | (3) |
|
|
37 Round and Punctate Calcifications |
|
|
311 | (4) |
|
|
38 Coarse Heterogeneous Calcifications |
|
|
315 | (4) |
|
|
39 Amorphous/Indistinct Calcifications (Group) |
|
|
319 | (7) |
|
|
40 Amorphous/Indistinct Calcifications (Regional/Diffuse) |
|
|
326 | (8) |
|
|
41 Fine, Linear/Branching Calcifications |
|
|
334 | (4) |
|
|
42 Pleomorphic Calcifications |
|
|
338 | (5) |
|
|
|
Section IV Nipple, Skin, and Lymph Nodes |
|
|
343 | (78) |
|
|
345 | (6) |
|
|
|
351 | (5) |
|
|
|
356 | (8) |
|
|
46 Intracystic/lntraductal Mass |
|
|
364 | (6) |
|
|
47 Complex Cystic and Solid Mass |
|
|
370 | (7) |
|
|
48 Skin and Trabecular Thickening |
|
|
377 | (10) |
|
|
|
387 | (7) |
|
|
|
394 | (9) |
|
|
|
403 | (11) |
|
|
52 Thrombophlebitis (Mondor Disease) |
|
|
414 | (7) |
|
|
Section V Intervention and Surgical Change |
|
|
421 | (92) |
|
53 Cyst/Abscess Aspiration |
|
|
423 | (3) |
|
|
|
426 | (7) |
|
|
55 Stereotactic Core Biopsy |
|
|
433 | (6) |
|
|
56 Ultrasound-Guided Core Biopsy |
|
|
439 | (8) |
|
|
57 MRI-Guided Core Biopsy |
|
|
447 | (13) |
|
|
58 Radiology-Pathology Correlation |
|
|
460 | (6) |
|
|
|
59 Pre-Operative Localization |
|
|
466 | (8) |
|
|
|
474 | (8) |
|
|
|
|
482 | (13) |
|
|
62 Post-Lumpectomy/Post-Radiation Breast |
|
|
495 | (8) |
|
|
|
63 Post-Reconstruction Breast |
|
|
503 | (10) |
|
Index |
|
513 | |